US Tech 100

19,268.40

0.53%

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

UCB

UCB (UCB)

UCB SA

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:EU:UCB

1 2 3 4 5 6 Next >>

Date	Time	Source	Headline	Symbol	Company
03/22/2024	1:00AM	GlobeNewswire Inc.	UCB Convening Notice to the General Meeting of the Shareholders 2024	EU:UCB	UCB SA
03/22/2024	1:00AM	GlobeNewswire Inc.	UCB Convocation à l'Assemblée Générale des Actionnaires 2024	EU:UCB	UCB SA
05/24/2023	8:25AM	GlobeNewswire Inc.	ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery	EU:UCB	UCB SA
03/24/2023	1:30AM	GlobeNewswire Inc.	UCB Convocation à L’ Assemblée Générale des Actionnaires 2023	EU:UCB	UCB SA
03/24/2023	1:30AM	GlobeNewswire Inc.	UCB Convening Notice to the General Meeting of theShareholders 2023	EU:UCB	UCB SA
12/13/2022	3:01PM	GlobeNewswire Inc.	Praxis Precision Medicines and UCB Announce Epilepsy Research Collaboration	EU:UCB	UCB SA
03/25/2022	1:00AM	GlobeNewswire Inc.	UCB SA - CONVOCATION A L’ASSEMBLEE GENERALE DES ACTIONNAIRES 2022	EU:UCB	UCB SA
03/25/2022	1:00AM	GlobeNewswire Inc.	UCB SA/NV - CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS 2022	EU:UCB	UCB SA
03/26/2021	1:00AM	GlobeNewswire Inc.	UCB SA - convocation à l'assemblée générale ordinaire	EU:UCB	UCB SA
03/26/2021	1:00AM	GlobeNewswire Inc.	UCB SA/NV - Convening notice annual shareholders meeting	EU:UCB	UCB SA
03/27/2020	1:00AM	GlobeNewswire Inc.	UCB SA : Convocation à l'assemblée générale des actionnaires	EU:UCB	UCB SA
03/27/2020	1:00AM	GlobeNewswire Inc.	UCB SA/NV : Convening notice to the general meeting of shareholders	EU:UCB	UCB SA
03/22/2019	1:00AM	GlobeNewswire Inc.	UCB SA : Convocation à l'assemblée générale des actionnaires qui se tiendra à Bluepoint Brussels	EU:UCB	UCB SA
03/22/2019	1:00AM	GlobeNewswire Inc.	UCB SA/NV: Convening Notice to attend the general meeting of shareholders to be held at Bluepoint Brussels	EU:UCB	UCB SA
10/23/2018	12:00AM	GlobeNewswire Inc.	UCB and Biogen Announce Topline Results from a Phase 2b Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus	EU:UCB	UCB SA
04/20/2018	6:55AM	Cercle Finance	UCB: met la main sur un antiépileptique	EU:UCB	UCB SA
02/22/2018	7:42AM	Cercle Finance	UCB: bien orienté après des résultats solides	EU:UCB	UCB SA
11/06/2017	3:01PM	GlobeNewswire Inc.	Dermira and UCB Agree to End Collaboration Agreement for CIMZIA	EU:UCB	UCB SA
09/14/2017	7:00AM	GlobeNewswire Inc.	New CIMZIA® (certolizumab pegol) Findings Presented at European Academy of Dermatology and Venereology (EADV) Congress	EU:UCB	UCB SA
07/25/2017	12:00AM	GlobeNewswire Inc.	UCB and Dermira Announce U.S. and EU Regulatory Submissions for CIMZIA® (certolizumab pegol) for the treatment of Moderate-t...	EU:UCB	UCB SA
05/23/2017	10:57AM	Cercle Finance	UCB: poursuit son repli après le problème d'essai clinique.	EU:UCB	UCB SA
05/22/2017	4:07AM	Cercle Finance	UCB: plonge après des problèmes sur son Evenity.	EU:UCB	UCB SA
01/19/2017	1:00AM	GlobeNewswire Inc.	Final CIMZIA® (certolizumab pegol) Phase 3 Trial Meets Primary Efficacy Endpoint in Patients with Moderate-to-Severe Chronic...	EU:UCB	UCB SA
01/11/2017	5:11AM	Cercle Finance	UCB: bien orienté, un analyste en soutien.	EU:UCB	UCB SA
12/08/2016	1:00AM	GlobeNewswire Inc.	Second CIMZIA® (certolizumab pegol) Phase 3 Trial Meets Co-primary Efficacy Endpoints in Patients with Moderate-to-Severe Ch...	EU:UCB	UCB SA
08/15/2016	4:27AM	Cercle Finance	UCB: salué pour une décision de justice aux Etats-Unis.	EU:UCB	UCB SA
04/25/2016	7:54AM	Cercle Finance	UCB: hausse de 11% du CA au 1er trimestre.	EU:UCB	UCB SA
03/08/2016	7:56AM	Cercle Finance	UCB: miné par une dégradation de broker.	EU:UCB	UCB SA
09/08/2015	8:35AM	Cercle Finance	UCB: soutenu par un relèvement de broker.	EU:UCB	UCB SA
09/03/2015	2:42AM	Cercle Finance	UCB: en tête du Bel 20 après la cession de Kremers.	EU:UCB	UCB SA